Jay Therrien's Biography

Home
|
Register
|
Submissions
|
Agenda
|
Exhibition
|
Venue
|
Media
|
Posters
|
Short Courses
- Training Courses
|

Jay Therrien, Vice President, Rain Dance Technologies

Prior to joining RainDance Technologies, Dr. Therrien was Vice President, Commercial Operations, Sequencing at Life Technologies, where he directed sales and support activities for the Sanger capillary electrophoresis (CE), SOLiD™, and Ion Torrent sequencing franchises. He previously held sales leadership roles at Illumina, including Director of Sales for Asia-Pacific and Japan. He has a B.S. from the University of Illinois at Urbana-Champaign and a Ph.D. from the University of Kansas.

Detecting Circulating Nucleic Acids by Fluid Biopsy™ and Profiling Somatic Tumors with Next-Gen DNA Sequencing

Tuesday, 28 October 2014 at 13:15

Add to Calendar ▼2014-10-28 13:15:002014-10-28 14:15:00Europe/LondonDetecting Circulating Nucleic Acids by Fluid Biopsy™ and Profiling Somatic Tumors with Next-Gen DNA SequencingSELECTBIOenquiries@selectbiosciences.com

RainDance Technologies is enabling ground-breaking research with a portfolio of picodroplet-based products for elucidating genetic targets for disease risk predisposition, initial detection, pathology and residual disease research. Hear about how the new ThunderBolts™ Cancer Panel is being deployed to rapidly detect and cost-effectively profile tumor samples and the ultra-sensitive RainDrop™ Digital PCR System is being used for follow-up mutation validation. This combination is compatible with all types of DNA, including FFPE, tissue and plasma and features a streamlined workflow and low overall cost per sample.

Add to Calendar ▼2014-10-27 00:00:002014-10-28 00:00:00Europe/LondonBiofluid BiopsiesSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors